Fundz

Cingulate Inc. reported raising in an initial SEC Form D filing, from an offering of $220 Million

PUBLIC · CINGSep 28, 2021$0 of $220M raised

Round Type

Venture

Kansas CityBiotechnologyHealthcareHealth CarePharmaceuticalBiopharma

Who else raised in Healthcare and Pharmaceutical around the same time

Companies in the same sectors as Cingulate that raised within 45 days of this round, from Fundz verified event records.

Who to call at Cingulate, and when

A new round usually means Cingulate is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cingulate raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cingulate, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cingulate. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cingulate

Location

Kansas City, Kansas, United States

About

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cingulate raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts7 people are listed at Cingulate. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cingulate's next move

See what Strategic adds

Cingulate raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.